sars-cov-2 News
-
QuarkBio has obtained the Ministry of Health and Welfare’s manufacturing approval for DigiChi SARS-CoV-2 Assay Kit
QuarkBio’s DigiChip™ SARS-CoV-2 Assay Kit has received manufacturing approval from Taiwan Ministry of Health and Welfare as part of the “Approved List of Medical Device Manufacturing Application for SARS-CoV-2”. The approval period is from November 23, 2020, to December 31, 2021. Approval number: 1096818270; Approved products: DigiChip™ SARS-CoV-2 ...
-
New Vitassay qPCR kit for SARS-CoV-2 UK Variant detection
The new Vitassay Real Time PCR allows the qualitative detection of SARS-CoV-2 and the HV 69/70 deletion of the S gene for SARS-CoV-2 in respiratory samples. Several SARS-CoV-2 variants of concern (VOC) have emerged in the past months and monitoring them in all countries is key. The United Kingdom (UK) has detected a new variant of SARS-CoV-2 from samples initially taken in Kent on September 20th ...
-
nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis
nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the human heart are mimicked by the SARS-CoV-2 polyprotein (replicase). The study has been submitted for peer-review. Authors of "Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: ...
-
New Vitassay Rapid Test for SARS-CoV-2 detection
The new Vitassay SARS-CoV-2 is a rapid, immunochromatographic, one step assay for the qualitative detection of SARS-CoV-2 from nasopharyngeal samples. Simple and highly sensitivity immunoassay for professional in vitro use only. SARS-CoV-2 infection can affect individuals of any age. The disease currently causes an overwhelming hospitalization of infected patients, presenting symptoms such as ...
-
EPA Announces the Approval of 13 Additional Products Effective against SARS-CoV-2
On July 30, 2020, the U.S. Environmental Protection Agency (EPA) announced it approved amended labels for 13 products based on laboratory testing that shows the products are effective against SARS-CoV-2, the virus that causes COVID-19. These products, and two previously announced products (see our July 7, 2020, blog), are the only products for which EPA has reviewed laboratory testing data and ...
-
Release of a new reference material for the detection of SARS-CoV-2 by RT-PCR.
The JRC released a new reference material for the detection of SARS-CoV-2 by real time RT-PCR. The material consists of a synthetic ssRNA (EURM-014) covering a fraction of the viral genome. It will be particularly useful for clinical or environmental diagnostic laboratories seeking quality and trust in their SARS-CoV-2 measurements. In 2020, the JRC issued a synthetic ssRNA molecule (EURM-019) ...
-
Bit225 Effective Against Established Sars-Cov-2 in Animals
The Directors are pleased to advise that the Company’s lead clinical drug, BIT225, has demonstrated effective protection from severe disease in mice with established SARS-CoV-2 infection in a new animal study performed at The SCRIPPS Research Institute, La Jolla, CA, USA. In a significant step forward, new data shows that BIT225 protects from severe disease even when started once there ...
-
Neutralizing Antibody Development for SARS-CoV-2 Available at Creative Biolabs
The continuous spread of COVID-19 has become a threat to global health and even has led to a global economic crisis. Researchers arounad the world are putting tremendous effort toward developing vaccines and therapeutic drugs. Creative Biolabs has been dedicated to the discovery and development of different types of vaccines, including in silico vaccine, live attenuated and killed vaccine, ...
-
Study from Scripps using SpyTag/SpyCatcher for display of SARS-CoV-2 RBD on ferritin nanoparticles for vaccine development
A study from Scripps using SpyTag/SpyCatcher technology shows that the receptor-binding domain and stabilized SARS-CoV-2 spike displayed on ferritin nanoparticles as vaccine antigens, elicited potent immune responses. ...
-
AbCellera-Discovered Antibody, Bebtelovimab, Receives U.S. FDA Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19
Bebtelovimab (LY-CoV1404) neutralizes Omicron, including the subvariant BA.2, as demonstrated by pseudovirus and/or authentic virus data Previously reported data show that bebtelovimab has broad and potent neutralization of all other known circulating SARS-CoV-2 variants of concern Bebtelovimab binds to a rarely mutated region of the SARS-CoV-2 spike protein, suggesting the potential to ...
-
EPA Announces Additional Procedures to Add New Disinfectant Products to List N and Creates New Web-Based Application Tool for Consumers to Find Disinfectant Products to Use Against SARS-CoV-2
On May 12, 2020, the U.S. Environmental Protection Agency (EPA) announced additional procedures for registrants to add new disinfectant products to EPA’s List N: Disinfectants for Use Against SARS-CoV-2 that are considered to be safe and effective for use against SARS-CoV-2, the virus that causes COVID-19. EPA states that it intends to expedite reviews of certain Pesticide Registration ...
-
Thermo Fisher Scientific Launches Customizable TaqMan SARS-CoV-2 Mutation Panel
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations. These assays enable surveillance of variants that are causing COVID-19 infections in specific regions globally and allow laboratories to choose which ...
-
Missing link in coronavirus jump from bats to humans could be pangolins, not snakes
As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus’ genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares “uncanny similarities” with an HIV-1 protein. Now, a study in ACS’ Journal of Proteome Research refutes both ideas and ...
-
The JRC releases new reference materials for the quality control of SARS-CoV-2 antibody tests
The JRC released two new reference materials, developed to function as quality assurance tools for the SARS-CoV-2 antibody tests used to verify if an individual has been infected by the COVID-19 virus. Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "The correct functioning of antibody tests is particularly important in epidemiological investigations to ...
-
FASTCURE: a consortium of experts to respond to the epidemic COVID-19 coronavirus outbreak
FASTCURE is a consortium of experts for screening, identification and formulation of chemical compounds to combat SARS-CoV-2. Drug repurposing can be a key strategy to fight against pathogens, especially when it comes as a rapid response to an emerging pathogen such as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) identified in Wuhan, China in January 2020, responsible for a ...
By Adjuvatis
-
Hot summer topic at AEESP: Focus on COVID-19
The founders of Aerosol Devices, Dr Susanne Hering and Ms Pat Keady will be both speaking as part of a critical line up of aerosol experts to discuss the latest research, methods of sampling and other important bio-aerosol topics related to the SAR-CoV-2 virus. Join us on Wednesday July 14th, ...
-
Congratulations! Reetoo COVID-19 Ag Self-Test kit obtained CE certification
Recently, Reetoo SARS-CoV-2 Antigen Rapid Self-test Kit (Colloidal Gold) received CE certification accredited by CeCert Sp. z o.o. and completed clinical validation in Vitalabo Laboratoria Medyczne Sp. z o.o. according to the latest EU guidance MDCG 2021-21 Guidance on performance evaluation of SARS-CoV-2 in vitro diagnostic, which means this product gained official access to the EU market. ...
-
SARS-CoV-2 Glycosylation Profiling Service Now Available at CD BioGlyco
CD BioGlyco, a biotechnology company that offers a full range of glycobiology-related products, analysis, custom synthesis, and design to help advance glycobiology research, now provides customers with comprehensive and accurate viral glycomics information to speed up the development of vaccines and other therapeutic agents during this COVID-19 pandemic. The US FDA has approved Pfizer and ...
By CD BioGlyco.
-
EPA Announces the Issuance of an Advisory on Disinfectants Making False and Misleading Claims against COVID-19
On June 1, 2020, the U.S. Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA) announced that it issued a compliance advisory on products claiming to kill SARS-CoV-2, the novel coronavirus that causes COVID-19. EPA states that the advisory was issued because it has received tips and complaints concerning potentially false or misleading claims, ...
-
BioGX COVID-19 Tests Detect Omicron SARS-CoV-2
BioGX, a global provider of molecular diagnostic solutions, announced that the Omicron (B.1.1.529), the latest emerging SARS-CoV-2 variant of concern, will be detected by the portfolio of BioGX SARS-CoV-2 products that target the nucleocapsid (N-gene) and envelope (E-gene) for detection of the virus. BioGX’s SARS-CoV-2 surveillance program includes exhaustive in-silico analysis and ...
By BioGX, Inc.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you